These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38997542)

  • 1. Correlation between neuropsychiatric systemic lupus erythematosus and immunological markers: a real-world retrospective study.
    Jiang Y; Yuan F; Xu X; Liu Y; Liang Y; Zhang Y; Lin Z; Zhao C
    Clin Rheumatol; 2024 Sep; 43(9):2833-2842. PubMed ID: 38997542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus.
    van der Meulen PM; Barendregt AM; Cuadrado E; Magro-Checa C; Steup-Beekman GM; Schonenberg-Meinema D; Van den Berg JM; Li QZ; Baars PA; Wouters D; Voskuyl AE; Ten Berge IRJM; Huizinga TWJ; Kuijpers TW
    Rheumatology (Oxford); 2017 Aug; 56(8):1407-1416. PubMed ID: 28460084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
    Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
    J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus.
    Mostafa GA; Ibrahim DH; Shehab AA; Mohammed AK
    J Neuroimmunol; 2010 Oct; 227(1-2):195-201. PubMed ID: 20724007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.
    Borowoy AM; Pope JE; Silverman E; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman D; Urowitz M; Zummer M; Hudson M; Tucker L; Peschken C
    Semin Arthritis Rheum; 2012 Oct; 42(2):179-85. PubMed ID: 22595642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    PLoS One; 2015; 10(3):e0119911. PubMed ID: 25781014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
    Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.
    Hirohata S; Sakuma Y; Yanagida T; Yoshio T
    Arthritis Res Ther; 2014 Oct; 16(5):450. PubMed ID: 25273532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.
    Tan Z; Zhou Y; Li X; Wang G; Tao J; Wang L; Ma Y; Li X
    Clin Rheumatol; 2018 Jan; 37(1):227-233. PubMed ID: 29103181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
    Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
    Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.
    Yang Y; Yuan C; Shen SQ; Wang XE; Mei QH; Jiang WQ; Huang Q
    Mediators Inflamm; 2017; 2017():5047898. PubMed ID: 28154472
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
    Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
    Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.